MGH performs its second, world’s fourth genetically altered pig kidney transplant
The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...
The American Journal of Managed Care13h
Evolent’s Wonsettler Sees Outcomes-Based Reimbursement as “A Healthy Tool”
Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from ...
ophthalmologyadvisor16h
Susvimo Approval Expanded to Include Diabetic Macular Edema
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
No-Moat Lundbeck's Strategic Brands Drive Growth but Face Generic Pressure Amid Patent Losses
However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...
U.S. Biomedical Leadership Threatened By NIH Licensing Guidelines
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
STAT18h
Experts fear disruptions at FDA as Trump offers buyouts and layoff reports swirl
The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.
The American Journal of Managed Care19h
The Uncertain Road Ahead for Health Care After DEI Rollbacks
The removal of FDA guidance on clinical trial diversity and related anti–diversity, equity, and inclusion (DEI) actions may hinder progress toward equitable health care, impacting workforce diversity, ...